Osaic Holdings
ALLR

Osaic Holdings’s Allarity Therapeutics ALLR Stock Holding History

Osaic Holdings’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7
Closed -$10 – 7837
2025
Q3 		$10 Hold
7
– – ﹤0.01% 7854
2025
Q2 		$7 Hold
7
– – ﹤0.01% 7700
2025
Q1 		$6 Buy
+7
New +$7 ﹤0.01% 7387

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings's ALLR Position: Q4 2025 in Review

Osaic Holdings sold out of Allarity Therapeutics (ALLR) in Q4 2025, closing a stake of 7 shares — an estimated $10 sold.

Osaic Holdings first reported a position in ALLR in Q1 2025 and held it in 3 quarters. The position peaked at $10 in Q3 2025. 16 funds tracked by Wall St. Rank hold ALLR as of Q4 2025.

  • Osaic Holdings reported no remaining Allarity Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 7 Allarity Therapeutics shares in Q4 2025, an estimated $10.
  • Osaic Holdings first reported a position in Allarity Therapeutics in Q1 2025 and held it in 3 quarters.
  • Osaic Holdings's Allarity Therapeutics position peaked at $10 in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.